UPDATE 1-Celgene 3rd quarter profit up 37 pct; edges above forecast
October 23, 2014 at 08:12 AM EDT
Oct 23 (Reuters) - Celgene Corp on Thursday reported third quarter profit rose 37 percent on a double-digit jump in sales of its flagship multiple myeloma medicine Revlimid and strong demand for its other drugs, and the U.S. biotechnology company raised its full-year earnings forecast by 5 cents.
